Find therapies in clinical trials near you – page 41

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

Study on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Study of Efgartigimod for Adults with Thyroid Eye Disease

Study of Efgartigimod for Adults with Thyroid Eye Disease

Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Study of belantamab mafodotin with bortezomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Study of belantamab mafodotin with bortezomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant

Study on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome

Study on the Effects of ARO-APOC3 for Adults with Familial Chylomicronemia Syndrome

Study of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency

Study of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency

Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

Study of Durvalumab and Tremelimumab for Patients with Advanced Unresectable Urothelial Cancer

Study of Durvalumab and Tremelimumab for Patients with Advanced Unresectable Urothelial Cancer